care ratings will conduct a Non-Deal Roadshow (NDR) to meet analysts and institutional investors on June 22, 2026, in Pune. The event is organized by Ambit Capital and is scheduled to commence at 10:00 AM. The meeting format will include both 1x1 and group sessions, providing a platform for the company's officials to engage with investors.

The company stated that discussions during the roadshow will be strictly based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be disclosed during these interactions. CARE Ratings noted that changes to the schedule may occur due to exigencies on the part of the participants or the company.

The intimation was submitted to the exchanges pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. The filing was signed by Manoj Kumar CV, Company Secretary & Compliance Officer.

The Investor Presentation for the event has already been made available on the company's official website. This document covers the financial performance for Q4 and FY26.

Meeting Details

CARE Ratings Limited has scheduled its 33rd Annual General Meeting (AGM) for Friday, July 3, 2026, at 3:30 p.m. IST via Video Conferencing. The meeting seeks shareholder approval for a final dividend of ₹14 per equity share. The record date for determining dividend entitlement and voting eligibility is fixed as Friday, June 26, 2026. The company reported an 18% year-on-year growth in consolidated revenue from operations to ₹473.07 crore for FY 2025-26, alongside a 24% rise in Profit After Tax to ₹173.70 crore.

AGM and E-Voting Schedule

The Notice of the 33rd AGM and the Annual Report for FY 2025-26 have been dispatched electronically to members with registered email addresses. Members holding shares in physical form are advised to register or update their PAN, KYC, and nomination details with the Registrar and Transfer Agent, KFin Technologies Limited. The facility for remote e-voting will be provided by NSDL.

Financial Performance for FY26

CARE Ratings delivered strong financial results in FY 2025-26. The company's standalone ratings income rose 15.16% during the year. Consolidated EBITDA stood at ₹197.40 crore, up 27% year-on-year, with an EBITDA margin of 42%.

Dividend Declaration

The Board has recommended a final dividend of ₹14 per equity share, amounting to ₹42.07 crore. During FY26, the company paid an interim dividend of ₹8 per equity share. The total dividend outflow for FY26 stood at ₹56.96 crore.